SIRION BIOTECH GMBH - Germany 

Ranking results:

Past rankings:

2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 0 5.998.603 454.500 1
2011 0 5.999.000 411.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
LUNDS UNIVERSITET2
UNIVERSITE LIBRE DE BRUXELLES2
A2F ASSOCIATES LIMITED1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DNA VISION1
FUNDACIO CENTRE DE REGULACIO GENOMICA1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INTOMICS AS1
KOBENHAVNS UNIVERSITET1
MEDIZINISCHE HOCHSCHULE HANNOVER1
SANFORDBURNHAM MEDICAL RESEARCH INSTITUTE1
STENO DIABETES CENTER1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
UNIVERSITA DI PISA1
UNIVERSITAT DE BARCELONA1
UNIVERSITE DE LAUSANNE1
VTT TECHNICAL RESEARCH CENTRE OF FINLAND1

Constancy:

Total number of partners: 21
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 21
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2016-01-01Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes T2DSystemsparticipant5.998.60312
2011-10-01Development of novel treatment strategies based on knowledge of cellular dysfunction in diabetes BetaBatparticipant5.999.00011